10th European Medical Information and Communications Conference and Exhibition

29 - 30 November 2016, Berlin, Germany
The 10th year of the Annual European Medical Information and Communications Conference is a unique meeting organised by medical information professionals for medical information professionals. Each year, speakers share hands-on experience dealing with current challenges as well as successes in medical information departments. Participants are encouraged to take part in the interactive workshop sessions and discussions happening throughout the conference. This conference is the one and only European forum dedicated to medical information and communications, making it the premier opportunity to network, exchange learnings, and share best practices.

Key Topics

  • Moving from traditional phone- and email-based channels to innovative digital channels to disseminate medical information
  • Examples of successes in digital presented by the most advanced players
  • Comparison between pharmaceuticals and medical devices - can the same strategies be used, or is a different approach needed?
  • Regulatory and legal issues: developments since the rejection of Safe Harbor - what's the impact of the new data privacy rules in Europe (Data privacy shield)
  • How to optimise collaboration between MSL and MedInfo roles
  • Effects of globalisation on different roles? How much localisation and how much globalisation is suitable?

Join the Annual European Medical Information and Communications Conference and find answers to issues of daily importance:

  • Are you clear on how to handle questions about off-label use?
  • Do you understand the latest changes in data privacy regulations?
  • Do you know the pros and cons of outsourcing medical information services?
  • How do you ensure high quality when you outsource customer service? Are you not happy with the quality of your outsourced customer services?
  • Is quality an issue in your outsourced medical information function?
  • Is your medical information website getting high enough usage? Learn how to improve hits and increase the number of users.
  • You have develop a website for customer service - now how do you get people to use your site? Is all your effort of building the site going to waste because nobody uses it?
  • How can you be successful in globalising medical information? From a local perspective, how can you best adapt and implement global guidelines?

Call for Poster Abstracts
Become an active part of the conference you attend by presenting a poster. Submit an abstract and take this opportunity to present your research and work to your peers at the conference. It's the perfect place for you to put your research into the limelight, to create discussions around your results with other professionals or to generate interest around a subject you feel needs more attention.

The European Medical Information and Communication Conference stretches across a variety of topics that you have encountered during your work. Contribute to the discussions at the conference by sharing your own experience. Please only submit abstracts matching the following topics:

  • From Safe Harbor to The EU/US Privacy Shield - What do you Need to Know in Medical Information?
  • The Future of Medical Information - Changing Modes of Communication
  • Globalization/Regionalization - Is it Possible to Have one Framework?
  • Medical Information and Medical Scientific Liaisons (MSLs) Partnerships
  • Providing Medical Information for Medical Devices
  • When Medical Information Goes On-line - Optimising the Sharing Experience
  • Considerations, User-Interface and Other Considerations
  • Supporting Established Products in Medical Information
  • Outsourcing and Insourcing Medical Information
  • Medical Information for Challenging Geographies

Deadline: Submit Poster Abstracts by Monday, 26 September 2016.

For further information, please visit:
http://www.diaglobal.org/en/conference-listing/meetings/2016/11/10th-annual-european-medical-information-and-communications-conference-and-exhibition

About DIA
For over 50 years, DIA has served as a global platform for more than 30,000 health care product development professionals, researchers, regulators, clinicians, academics and patient advocates to collaborate to improve health globally through the advancement of lifesaving medicines and technologies. As the premier professional community for the health care product development ecosystem, DIA (the Drug Information Association) provides global players a neutral and transparent forum for the exchange of ideas and collaboration. By offering access to tools, resources, and networking opportunities, DIA provides its members and international participants objective opportunities for extending debate and discussion to advance scientific and medical innovation.

DIA is an independent, global nonprofit organization based in Washington, DC, USA, with regional offices representing the Americas (Horsham, PA, USA); Europe, the Middle East, and Africa (Basel, Switzerland); and Asia (Beijing, China; Mumbai, India; and, Tokyo, Japan).

Most Popular Now

Delivering insulin in a pill

Given the choice of taking a pill or injecting oneself with a needle, most of us would opt to regulate a chronic health condition by swallowing a pill. But for millions o...

Can aspirin treat Alzheimer's?

A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological r...

Probiotics can protect the skeletons of older wome…

For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteri...

Alzheimer's breakthrough: Brain metals that may dr…

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegen...

FDA approves first drug comprised of an active ing…

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms o...

Researchers develop a new method for turning skin …

Our bodies consist of many different kinds of cells, each with their own role. The Japanese scientist Shinya Yamanaka had made earlier the discovery, earning the Nobel Pr...

Some existing anti-cancer drugs may act in part by…

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti...

FDA takes steps to foster greater efficiency in bi…

Today, the agency withdrew the draft guidance, "Statistical Approaches to Evaluate Analytical Similarity," issued in September 2017. The draft guidance, if finalized as w...

Poliovirus therapy for recurrent glioblastoma has …

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, wit...

Novartis Clear about Psoriasis survey data highlig…

Novartis announced today the publication of global Clear about Psoriasis survey data in the Journal of the European Academy of Dermatology and Venereology[1]. The publica...

Human clinical trial reveals verapamil as an effec…

Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce insulin requirements and...

How targeting metabolism can defeat cancer stem ce…

Researchers are the University of Michigan Rogel Cancer are unraveling a crucial thread that explains why cancer so often becomes resistant to treatment. In a breakthroug...